A detailed history of Brewin Dolphin Wealth Management LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 250 shares of JAZZ stock, worth $30,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$30,742
Previous $39,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Nov 14, 2022

BUY
$129.64 - $160.7 $32,409 - $40,175
250 New
250 $39,000
Q3 2021

Nov 09, 2023

SELL
$128.64 - $184.79 $1,800 - $2,587
-14 Closed
0 $0
Q2 2021

Nov 09, 2023

SELL
$160.2 - $186.42 $37,807 - $43,995
-236 Reduced 94.4%
14 $2.49 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.